Related references
Note: Only part of the references are listed.Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
Xiao-Su Zhao et al.
ANNALS OF HEMATOLOGY (2012)
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group
Thomas Klingebiel et al.
BLOOD (2010)
Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
Mohamad Mohty et al.
BLOOD (2010)
Regression modeling of competing risk using R: an in depth guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2010)
Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect
X-J Huang et al.
BONE MARROW TRANSPLANTATION (2009)
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
Nicolaus Kroeger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
A pilot study of low-dose recombinant interleukin-2 for acute lymphoblastic malignancy after unmanipulated allogeneic blood and marrow transplantation
K-Y Liu et al.
BONE MARROW TRANSPLANTATION (2008)
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study
Xiao-Jun Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Monitoring of minimal residual disease in acute myeloid leukemia
Wolfgang Kern et al.
CANCER (2008)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions
Xiao-Jun Huang et al.
TRANSPLANT IMMUNOLOGY (2007)
Treatment of relapsed acute leukemia after allogeneic transplantation: A single center experience
Martha L. Arellano et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia
H Lapillonne et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
ES Morris et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia
M Weisser et al.
LEUKEMIA (2005)
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB-MYH11+ acute myeloid leukemia based on quantification of fusion transcripts
S Schnittger et al.
BLOOD (2003)
Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow
L Garderet et al.
BONE MARROW TRANSPLANTATION (2003)
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
JF San Miguel et al.
BLOOD (2001)
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
T de Witte et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
